SAN ANTONIO, June 16 /PRNewswire/ -- BME (BioMedical Enterprises, Inc.), a privately held medical device company and leader in orthopaedic shape memory implant technology, today announced the launch of the Barbed OSStaple(TM) (BOSS), a nitinol implant designed for internal fixation of bone.
The BOSS is an orthopaedic nitinol implant with barbs on the legs for bone adhesion. Like the BME OSStaple(TM) product line, the BOSS nitinol staple changes shape when heated above body temperature to provide compression between two bones. The BOSS is ideal for upper and lower extremity procedures, especially when surgeons want the added security of barbed legs to stabilize the implant.
Made of nitinol, a biocompatible alloy possessing shape memory and super-elastic properties, the BOSS implant is inserted at room temperature. Using BME's patented OSSforce(TM) Implant Controller, the implant is safely heated above body temperature. During this process, the implant's legs and back change shape to compress bone. In addition, the movement of the legs causes the barbs to anchor more securely in bone. After heating, the nitinol structure transforms into a state approximately 20% stronger than 316L stainless steel. Due to nitinol's unique properties, the implant continues to maintain a compressive force in bone over time.
The BOSS implant, along with BME's OSSAnchor(TM) Grip soft tissue anchor, are the first orthopaedic nitinol implants to feature barbs for improved pull-out resistance, a new surface treatment that minimizes metal ion release, and a roughened surface texture for bone in-growth.
A national launch of the Barbed OSStaple(TM) will begin at the American Orthopaedic Foot and Ankle Society summer meeting in Denver, Colorado being held June 25-28.
BME is a medical device company that addresses the changing needs in musculoskeletal medicine. BME focuses on minimally invasive orthopaedic instrumentation and implants that elicit a biologic response. BME's focus on memory metal internal fixation implants is changing the shape of orthopaedic medicine. Its specialized history of musculoskeletal research services will continue to produce unique, state of the art orthopaedic products that provide better outcomes for patients and more convenience to surgeons. For more information visit http://www.bme-tx.com.
CONTACT: Eric Marcano, Marketing Manager of BioMedical Enterprises, Inc.,
1-800-880-6528, fax, 1-866-913-3977
Web site: http://www.bme-tx.com/